| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.09B | 37.06B | 33.73B | 31.88B | 29.50B | 30.45B |
| Gross Profit | 7.07B | 7.26B | 5.89B | 5.37B | 5.56B | 5.51B |
| EBITDA | 4.49B | 4.60B | 3.30B | 2.76B | 3.50B | 3.30B |
| Net Income | 2.97B | 3.05B | 1.91B | 1.64B | 2.14B | 2.13B |
Balance Sheet | ||||||
| Total Assets | 57.62B | 57.24B | 62.08B | 54.98B | 52.12B | 50.42B |
| Cash, Cash Equivalents and Short-Term Investments | 11.74B | 12.75B | 14.39B | 12.46B | 13.07B | 12.33B |
| Total Debt | 3.02B | 920.21M | 1.56B | 1.07B | 986.51M | 935.36M |
| Total Liabilities | 13.38B | 14.16B | 20.48B | 16.78B | 15.19B | 14.40B |
| Stockholders Equity | 43.76B | 42.61B | 41.13B | 37.90B | 36.63B | 35.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -596.51M | 2.07B | -37.02M | 501.88M | 2.89B |
| Operating Cash Flow | 0.00 | 897.21M | 2.77B | 649.98M | 972.88M | 3.60B |
| Investing Cash Flow | 0.00 | 36.60M | -121.63M | -757.59M | 561.83M | -1.16B |
| Financing Cash Flow | 0.00 | -2.53B | -790.56M | -519.52M | -823.73M | -473.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥45.49B | 14.35 | ― | 3.74% | 3.70% | 12.26% | |
75 Outperform | ¥141.70B | 9.90 | ― | 1.92% | 12.72% | 28.48% | |
66 Neutral | ¥114.16B | 13.03 | ― | 3.53% | -0.58% | -46.15% | |
66 Neutral | ¥127.83B | 10.42 | 12.89% | 3.40% | 2.98% | 41.11% | |
64 Neutral | ¥60.56B | 20.20 | ― | 1.49% | -8.92% | 1.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | ¥461.82B | 16.11 | 1.44% | 4.80% | 0.68% | ― |